KRMD
KORU Medical Systems, Inc.
KRMD lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
KRMD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
KRMD's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
KRMD PE Valuation
KRMD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 351x next year's earnings.
KRMD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect KRMD to return to profit, with revenue growing. However, they disagree widely on these estimates.
KRMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.01 | — |
| Q3 2026 | -$0.02 | +$0.07 |
| Q2 2026 | -$0.04 | +$0.06 |
| Q1 2026 | -$0.05 | +$0.07 |
| Q4 2025 | -$0.06 | +$0.07 |
| Q3 2025 | -$0.09 | +$0.17 |
| Q2 2025 | -$0.10 | +$0.16 |
| Q1 2025 | -$0.12 | +$0.17 |
| Q4 2024 | -$0.13 | +$0.17 |
KRMD is still losing money, but far less than before: $0.02 per share over the past year, against $0.30 at its worst in late 2023.
KRMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.6M | +11% |
| Q2 2026 | $12M | +18% |
| Q1 2026 | $11.8M | +22% |
| Q4 2025 | $10.9M | +23% |
| Q3 2025 | $10.4M | +27% |
| Q2 2025 | $10.2M | +21% |
| Q1 2025 | $9.6M | +18% |
| Q4 2024 | $8.8M | +23% |
KRMD's revenue has grown year over year for 11 quarters in a row: $12M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +10 points |
| Q2 2026 | 5.2% | +8.3 points |
| Q1 2026 | -7.3% | +5.6 points |
| Q4 2025 | -5% | +13 points |
| Q3 2025 | -8.3% | +13 points |
| Q2 2025 | -3.1% | +11 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -18% | +13 points |
KRMD's operating margin was 1.6% last quarter, up 10 points from the same quarter a year ago.
KRMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2M | -8973% |
| Q2 2026 | $108.2K | +$597.4K |
| Q1 2026 | -$31.5K | +$649.4K |
| Q4 2025 | $687K | -30% |
| Q3 2025 | $13K | +$2M |
| Q2 2025 | -$489.2K | -$376.2K |
| Q1 2025 | -$680.9K | -$201.1K |
| Q4 2024 | $983.2K | +9.2% |
KRMD has burned cash in most quarters: −$387,369 over the past year, against −$173,904 the year before.
KRMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.6% | -2.8M shares |
| 1 year | +1.1% | +493K shares |
| 3 years | +2.4% | +1.1M shares |
| 5 years | +5.4% | +2.4M shares |
| Available history | +20% | +7.7M shares |
KRMD has 47M diluted shares, up 1.1% from a year ago.
KRMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -37.0x | Net Cash |
| Q3 2020 | -239.5x | Net Cash |
| Q2 2020 | -60.9x | Net Cash |
| Q1 2020 | -3.6x | Net Cash |
| Q4 2019 | -6.3x | Net Cash |
KRMD has more cash than debt.
KRMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 30.9 | Neutral |
KRMD's weekly RSI is 53 (neutral) and its Stochastic is 31 (neutral).
KRMD PE vs Healthcare Sector
| Metric | KRMD | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
KRMD has no meaningful PE right now: it lost money over the past year.
KRMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.13 | 18% above |
| 20 week MA | $3.45 | 7% above |
| 50 week MA | $4.20 | 12% below |
| 100 week MA | $3.92 | 5.9% below |
| 200 week MA | $3.39 | 8.8% above |
KRMD's trend is mixed: it's above three of its five weekly moving averages, and 8.8% above its 200-week average.
KRMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.15 | $6.09 | -1% |
| 2021 | $6.09 | $3.25 | -47% |
| 2022 | $3.25 | $3.42 | +5.2% |
| 2023 | $3.42 | $2.46 | -28% |
| 2024 | $2.46 | $3.94 | +60% |
| 2025 | $3.94 | $6.23 | +58% |
| 2026 YTD | $6.23 | $3.69 | -41% |
KRMD has finished lower in three of the last six years. It's down 41% so far in 2026.